Table 1 Demographic and clinical parameters
From: Predictive value of standard serum markers for bone metastases in prostate cancer
Clinical parameters | Patients cohort (n = 175) | ||
|---|---|---|---|
Mean ± SD | Median | Min.–Max. | |
A.ge (years) | 71.36 ± 8.61 | 71.00 | 48–88 |
Free PSA (ng/ml) (n = 95) | 19.21 ± 43.02 | 2.93 | 0–235 |
Total PSA (ng/ml) (n = 175) | 87.84 ± 299.83 | 14.95 | 0–2934 |
Free/total PSA (n = 96) | 0.236 ± 0.220 | 0.18 | 0–1.67 |
Alkaline phosphatase(U/L) (n = 57) | 181.87 ± 283.46 | 91.00 | 12.80 ± 1722 |
Gleason score (n = 120) | 7.75 ± 1.43 | 8.00 | 4–10 |
Number of metastatic foci (n = 175) | 9.68 ± 12.13 | 2.00 | 0–30 |